Letter 1: Randomized clinical trial of preoperative intravenous iron sucrose to reduce blood transfusion in anaemic patients after colorectal cancer surgery (Br J Surg 2009; 96: 1122-1128)

British Journal of Surgery

Volumn 97, Issue 2, 2010, Pages 297-298

  Ranganathan, P ^a   Pramesh, C S ^a  

^a TATA MEMORIAL HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANEMIC AGENT; FERRIC ION; FERRIC OXIDE, SACCHARATED;

BLOOD TRANSFUSION; COLORECTAL TUMOR; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; IRON DEFICIENCY ANEMIA; LETTER; POSTOPERATIVE COMPLICATION; RANDOMIZED CONTROLLED TRIAL;

ANEMIA, IRON-DEFICIENCY; BLOOD TRANSFUSION; COLORECTAL NEOPLASMS; FERRIC COMPOUNDS; HEMATINICS; HUMANS; INFUSIONS, INTRAVENOUS; POSTOPERATIVE COMPLICATIONS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 74549197607     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.6980     Document Type: Letter

References (3)

1. Cook J. Diagnosis and management of iron-deficiency anaemia. Best Pract Res Clin Haematol 2005; 18: 319-332.
2. Beris P, Muñoz M, García-Erce JA, Thomas D, Maniatis A, Van der Linden P. Perioperative anaemia management: consensus statement on the role of intravenous iron. Br J Anaesth 2008; 100: 599-604.
3. Chertow GM, Mason PD, Vaage-Nilsen O, Ahlmén J. Update on adverse drug events associated with parenteral iron. Nephrol Dial Transplant 2006; 21: 378-382.